We Are JPEO

The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) manages our nation’s investments in chemical, biological, radiological, and nuclear (CBRN) defense equipment and medical countermeasures.

The JPEO-CBRND leads, manages, and directs the acquisition, fielding and sustainment of CBRN sensors, protective equipment, medical countermeasures, specialized equipment for U.S. Special Forces, integration and information management systems, and defense enabling biotechnologies. The organization also works closely with various government agencies that need CBRN defense equipment. The JPEO-CBRND is one of the Chemical and Biological Defense Program’s four components. The Deputy Assistant Secretary of Defense for Chemical and Biological Defense oversees this program. The Assistant Secretary of the Army for Acquisition, Logistics, and Technology (ASA(ALT)), who is the Army Acquisition Executive, delegates JPEO-CBRND’s acquisition authority.

Learn more about the Joint Project Management Offices for CBRN Protection, CBRN Medical, CBRN Sensors, and CBRN SOF, and the Joint Project Lead Offices for CBRND Enabling Biotechnologies and CBRN Integration.

Learn more about the JPEO-CBRND

Our Mission

Provide integrated layered chemical, biological, radiological, and nuclear defense capabilities to the Joint Force across Combined Joint All-Domain Operations

Our Vision

A resilient Joint Force enabled to fight and win unencumbered by a chemical, biological, radiological, or nuclear environment; championed by innovative, agile, results-oriented acquisition professionals

Partnering Benefits

 

Work with the JPEO-CBRND on providing solutions that protect the Joint Force and the Warfighter from weapons of mass destruction. Help us achieve our vision of a resilient Joint Force that's enabled to fight and win unencumbered by CBRN environments.

Innovative Contracting Experience iconInnovative Contracting Experience

Our Other Transactional Authority (OTA) agreements enable enhanced communications and support innovation. 

Agile Execution iconAgile Execution

We face a complex threat environment, so we need the partnership and support of industry and academia to help us innovate at the speed of relevancy for our current CBRN defense environments.

Share iconShare Your Latest Insights with Government

The JPEO-CBRND is eager to learn more about the latest innovations, capabilities and insights to help support the Joint Force and protect our Warfighters. 

Keep Current iconKeep Current on the CBRND Industrial Base’s Needs

Gain insight into the way ahead for our organization as well as our CBRND partners.

Modernize iconHelp Modernize the Joint Force 

Help establish and refine the long-term vision for CBRND capabilities.

Speed iconDevelopment at the Speed of Relevancy

Help the JPEO-CBRND tackle the R&D needs on the horizon and learn more about our “new start” programs here.

Events

2022 Aberdeen Proving Ground (APG) Advanced Planning Briefing to Industry (APBI)
April 26-28, Aberdeen Proving Ground (Virtual), Maryland

📁 Download the slides

Featured Technologies

Joint Service General Purpose Mask (JSGPM)

Joint Service General Purpose Mask (JSGPM)

LEARN MORE

Next Generation Diagnostics System 1 (NGDS 1)

Next Generation Diagnostics System 1 (NGDS 1)

LEARN MORE

Nuclear, Biological, Chemical Reconnaissance Vehicle

Nuclear, Biological, Chemical Reconnaissance Vehicle (NBCRV)

LEARN MORE

News

While wearing MOPP Level 4 gear a test player prepares to use a ROCS auto-injector on a simulated causality.

DOD-Supported 10mg Naloxone Autoinjector Receives FDA Approval to Treat Known or Potential Ultra-Potent Opioid Exposure

News
Mar. 17, 2022

On February 28, 2022, the FDA approved a 10mg naloxone autoinjector designed for non-medically trained users...
Read More
American flags against a blue sky background

DOD Awards Contracts to Purchase COVID-19 Antigen Over-the-Counter Test Kits in Support of POTUS’ One Billion Free At-Home COVID-19 Tests

News
Feb. 18, 2022

This week, the DoD, in coordination with HHS, awarded contract modifications to Roche Diagnostics Corporation...
Read More
h

DOD Awards $250 Million Contract to Ology Bioservices, Inc., for Botulinum Monoclonal Antibody Advanced Development through FDA Licensure

News
Feb. 10, 2022

The JPEO-CBRND's Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN...
Read More
A servicemember sits in a yellow shirt in front of a table of red and blue testing vials. Covi

DOD Awards Contract to Siemens Healthineers to Purchase COVID-19 Antigen Over-the-Counter Test Kits in Support of POTUS' 500 Million Free At-Home COVID-19 Tests

News
Jan. 24, 2022

On Jan. 21, 2022, the Department of Defense (DoD), in coordination with the U.S. Department of Health and...
Read More
American flags against a blue sky background

DOD Awards Contracts to Purchase COVID-19 Antigen Over-the-Counter Test Kits in Support of POTUS' 500 Million Free At-Home COVID-19 Tests

News
Jan. 14, 2022

Today, the Department of Defense (DoD), in coordination with the U.S. Department of Health and Human Services...
Read More
American flags against a blue sky background

Biden Administration Secures 10 Million Courses of Pfizer’s COVID-19 Oral Antiviral Medicine as Additional Tool to Reduce Hospitalizations and Save Lives

News
Nov. 18, 2021

As part of its ongoing efforts to curb the pandemic, reduce hospitalizations, and save lives, the Biden...
Read More
The appearance of hyperlinks does not constitute endorsement by the JPEO-CBRND of non-U.S. Government sites or the information, products, or services contained therein. Although the JPEO-CBRND may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such hyperlinks are provided consistent with the stated purpose of this website.